• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HAEMONETICS, INC. TEG® 5000 THROMBELASTOGRAPH® HEMOSTASIS ANALYZER; TEG MANAGER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HAEMONETICS, INC. TEG® 5000 THROMBELASTOGRAPH® HEMOSTASIS ANALYZER; TEG MANAGER Back to Search Results
Model Number TGV-2739
Device Problem Computer Software Problem (1112)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/07/2021
Event Type  malfunction  
Manufacturer Narrative
The tas database in use at the facility had in total (b)(4) tracings and had been in use for over a year (it was created on 10/14/2020).Prior to the creation of that database, an it administrator at the facility had been archiving and creating a new database on roughly a monthly basis.After the it administrator left the position, database archival was no longer being performed.The large size of the database could have contributed to the teg manager agent incorrectly reading from the tas patient database to retrieve the calculated inhibition/aggregation results for a teg 5000 result.It was not able to be proven that this was the root cause of this issue during testing, however from haemonetics analysis, it is believed that the database size played a big role in causing this event.In order to reduce the chance of a large database leading to issues with erroneous results, customers need to be diligent about compacting and archiving their tas patient database on a regular basis.Implementing a warning message into the teg manager agent that alerts the end user when the database needs to be archived will help reduce chances of a large database leading to erroneous inhibition/aggregation test results.Improving labeling to inform customers on the need for database compacting/archiving could also help raise awareness of this issue.
 
Event Description
On november 19, 2021, haemonetics was made aware of a customer complaint describing an instance where the adp inhibition/aggregation for a teg 5000 plateletmapping adp cluster displayed incorrectly in teg manager.The plateletmapping adp inhibition/aggregation displays correctly in tas.The medical director at the user facility initially noticed the discrepancy when reviewing the result in teg manager.The physician was not aware of any treatment given to the patient based on the erroneous result and there was no reported harm or injury to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TEG® 5000 THROMBELASTOGRAPH® HEMOSTASIS ANALYZER
Type of Device
TEG MANAGER
Manufacturer (Section D)
HAEMONETICS, INC.
125 summer street
boston MA 02110
Manufacturer (Section G)
HAEMONETICS, INC.
125 summer street
boston MA 02110
Manufacturer Contact
brenda bruyere
125 summer street
boston, MA 02110
MDR Report Key12979757
MDR Text Key285758686
Report Number1219343-2021-00152
Device Sequence Number1
Product Code JPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K993678
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTGV-2739
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/19/2021
Initial Date FDA Received12/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-